drugset / Trial / NCT00124267

Efficacy of Intrarectal Versus Intravenous Quinine for the Treatment of Childhood Cerebral Malaria

NCT00124267

RandomizedParallel-groupDouble-blindTreatment

Summary

Cerebral malaria is the most lethal complication of P.falciparum infection with a mortality rate between 5 and 40%. Intravenous quinine remains the recommended treatment for cerebral malaria. However its administration is often not feasible due to lack of simple equipment or trained staff. When referral is not possible, a viable alternative is needed. The intrarectal route is of interest in children since it is painless and simple. Studies of the efficacy of intrarectal quinine in the treatment of cerebral malaria are limited. The study aims to establish the efficacy of intrarectal quinine in the treatment of childhood cerebral malaria.

Timeline

Start
2003-09
Primary completion
Completion
2004-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinine Small molecule 15 mg/kg Rectal

Indications